Sophiris Bio Inc (SPHS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

1258 PROSPECT STREET LA JOLLA, CA 92037

Protox Therapeutics Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel receptor targeted therapeutic fusion proteins.

Data as of 2021-05-08 10:49:38 -0400
Market Cap711.009 Thousand Shares Outstanding35.55 Million Avg 30-day Volume123.738 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low0.25 / 0.0035 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from SPHS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 1 1 0.0% (0.0%) (0.0%)
13F shares: 490 490 0.0%
% Ownership 0.0004
New Positions:
Increased Positions
Closed Positions
Reduced Positions
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SPHS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SPHS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WOODS RANDALL E PRESIDENT & CHIEF EXEC OFFICER

  • Officer
  • Director
0 2019-12-19 0

HULME ALLISON CHIEF OPERATING OFFICER

  • Officer
  • Director
0 2019-12-19 0

SLOVER PETER T CHIEF FINANCIAL OFFICER

  • Officer
0 2019-12-19 0

GELTOSKY JOHN

  • Director
0 2019-06-27 0

EKMAN LARS

  • Director
0 2019-06-27 0

HEPPELL JAMES L

  • Director
0 2019-06-27 0

PROEHL GERALD T

  • Director
0 2019-06-27 0

TURNER JOSEPH L

  • Director
0 2015-05-27 0

BOXER CAPITAL, LLC

BOXER ASSET MANAGEMENT INC.

LEWIS JOSEPH

MVA INVESTORS, LLC

  • 10% Owner
161,447 2014-12-15 0

ROHN WILLIAM R

  • Director
0 2013-10-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SOPHIRIS BIO INC SPHS 2021-05-11 22:15:03 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 21:45:03 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 21:15:03 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 20:45:03 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 20:15:03 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 19:45:03 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 19:15:02 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 18:45:02 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 18:15:03 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 17:45:03 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 17:15:04 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 16:45:04 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 16:15:04 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 15:45:03 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 15:15:03 UTC -13.1702 13.2202 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 14:45:03 UTC -13.1715 13.2215 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 14:15:03 UTC -13.1715 13.2215 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 13:45:04 UTC -13.1715 13.2215 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 13:15:04 UTC -13.1715 13.2215 1000000
SOPHIRIS BIO INC SPHS 2021-05-11 12:45:03 UTC -13.1715 13.2215 1000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments